Oramed Pharmaceuticals (ORMP) Insider Trading & Ownership → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free ORMP Stock Alerts $2.30 -0.03 (-1.29%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Oramed Pharmaceuticals (NASDAQ:ORMP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.00%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$293,240.00Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$5.13 M Get ORMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORMP Insider Buying and Selling by Quarter Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Oramed Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/16/2023Nadav KidronCEOBuy26,000$2.04$53,040.00 3/14/2023Nadav KidronCEOBuy100,000$2.01$201,000.00 3/13/2023Yadin RozovDirectorBuy20,000$1.96$39,200.00 1/3/2023Michael RabinowitzInsiderSell13,325$12.55$167,228.75 3/21/2022Kevin RakinDirectorSell10,000$9.41$94,100.00 1/14/2022Andrew R. GarbarinoU.S. Congress Member (R-NY)Sell$11.05$1,001 - $15,00010/1/2021Andrew R. GarbarinoU.S. Congress Member (R-NY)Sell$20.93$1,001 - $15,0009/16/2021Kevin RakinDirectorSell21,100$20.99$442,889.00 8/9/2021Nadav KidronCEOSell220,000$20.11$4,424,200.00 (Data available from 1/1/2013 forward) ORMP Insider Trading Activity - Frequently Asked Questions Who is on Oramed Pharmaceuticals's Insider Roster? The list of insiders at Oramed Pharmaceuticals includes Kevin Rakin, Michael Rabinowitz, Nadav Kidron, and Yadin Rozov. Learn more on insiders at ORMP. What percentage of Oramed Pharmaceuticals stock is owned by insiders? 12.00% of Oramed Pharmaceuticals stock is owned by insiders. Learn more on ORMP's insider holdings. Which Oramed Pharmaceuticals insiders have been buying company stock? The following insiders have purchased ORMP shares in the last 24 months: Nadav Kidron ($254,040.00), and Yadin Rozov ($39,200.00). How much insider buying is happening at Oramed Pharmaceuticals? Insiders have purchased a total of 146,000 ORMP shares in the last 24 months for a total of $293,240.00 bought. Which Oramed Pharmaceuticals insiders have been selling company stock? The following insider sold ORMP shares in the last 24 months: Michael Rabinowitz ($167,228.75). How much insider selling is happening at Oramed Pharmaceuticals? Insiders have sold a total of 13,325 Oramed Pharmaceuticals shares in the last 24 months for a total of $167,228.75 sold. More Insider Trading Tools from MarketBeat Related Companies: Assertio Insider Trading Genelux Insider Trading Clearside Biomedical Insider Trading Allakos Insider Trading Anixa Biosciences Insider Trading IO Biotech Insider Trading Eton Pharmaceuticals Insider Trading Q32 Bio Insider Trading ProPhase Labs Insider Trading Annovis Bio Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:ORMP) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.